Skip to main content
Caplight Logo









Inquis Medical

Inquis Medical

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://inquismedical.com/

Last Round

Series C

Jan 12, 2026

Est. Valuation

$375M

Total Funding Raised

$115M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Inquis Medical is a medical device company that develops next-generation peripheral thrombectomy technology aimed at enhancing the management of venous thromboembolic diseases while minimizing blood loss during procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

mechanical thrombectomyvenous thromboembolismVTEpulmonary embolismPEdeep vein thrombosisDVTclot removalautologous blood transfusiontissue-sensing technologyvascular interventionaspiration thrombectomymedical devicethrombectomy deviceclot buster

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inquis Medical Comparables

Compare Inquis Medical with similar companies based on industry and business-model similarity.

Inquis Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Akura Medical
90%
Imperative Care
88%
Stryker Corporation
87%

Inquis Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 12, 2026
Series BNov 4, 2024

Key People

Founding team and executive leadership

Mojgan Saadat

Co-CEO President

Executive Team

Vahid Saadat

Co-CEO

Executive Team

Eric Steuben

Chief Operating Officer

Executive Team

Inquis Medical Investors

Notable investors and investment history

Inquis Medical investors
InvestorRounds
ShangBay CapitalSeries B
Marshall WaceSeries B
Yu GalaxySeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2026

    Open roles increased to 38, 48% of headcount.

  • Jun 20, 2026

    Monthly visitors increased 63% MoM, reaching 4K.

Inquis Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inquis Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inquis Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range84
Year Founded2020
Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?